×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CLSD – clearside biomedical, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CLSD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/16
03:06 am
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
11/15
06:04 pm
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $6.00 price target on the stock.
Low
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $6.00 price target on the stock.
11/15
01:50 pm
clsd
All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy [Yahoo! Finance]
Low
Report
All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy [Yahoo! Finance]
11/15
06:59 am
clsd
Clearside Biomedical Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
Clearside Biomedical Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/14
08:15 am
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Low
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
11/13
08:05 am
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $6.00 price target on the stock.
Low
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $6.00 price target on the stock.
11/13
02:26 am
clsd
Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Call Highlights: Promising Clinical Trial ... [Yahoo! Finance]
Medium
Report
Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Call Highlights: Promising Clinical Trial ... [Yahoo! Finance]
11/12
04:12 pm
clsd
Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2024
04:05 pm
clsd
clearside biomedical, inc.
BEAT
Report
-2.7%
clearside biomedical, inc.
8/12/2024
04:05 pm
clsd
clearside biomedical, inc.
BEAT
Report
-0.5%
clearside biomedical, inc.
5/9/2024
04:05 pm
clsd
clearside biomedical, inc.
MISS
Report
-7.4%
clearside biomedical, inc.
3/12/2024
04:05 pm
clsd
clearside biomedical, inc.
BEAT
Report
-5.2%
clearside biomedical, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/12
04:17 pm
clsd
Form 10-Q Clearside Biomedical, For: Sep 30
Medium
Report
Form 10-Q Clearside Biomedical, For: Sep 30
11/12
04:11 pm
clsd
Form 8-K Clearside Biomedical, For: Nov 12
Low
Report
Form 8-K Clearside Biomedical, For: Nov 12
11/4
04:15 pm
clsd
Form 4 Clearside Biomedical, For: Nov 01 Filed by: Chong Ngai Hang Victor
Low
Report
Form 4 Clearside Biomedical, For: Nov 01 Filed by: Chong Ngai Hang Victor
10/9
07:56 am
clsd
Form 8-K Clearside Biomedical, For: Oct 09
High
Report
Form 8-K Clearside Biomedical, For: Oct 09
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
1/6
Clearside Biomedical to Present at the 38th Annual J.P. Morgan Healthcare Conference
29.2%
8/7 Q2/2019 6/30/2019 EPS -0.150 ZacksConsensus -0.370 ActVsEst 0.220 - Beat 28.0%
10/22 Clearside Biomedical Inc (NASDAQ: CLSD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $1.00 price target on the stock. 19.0%
9/3 Clearside Biomedical to Present at the Janney Montgomery Scott Healthcare Conference 16.0%
11/26 Form 4 Clearside Biomedical, For: Nov 22 Filed by: Thorp Clay 12.5%
4/8 Clearside Biomedical to Present at the Needham Virtual Healthcare Conference 11.7%
10/3 Clearside Biomedical Announces Multiple Presentations to be Given at the American Academy of Ophthalmology (AAO) 2019 Annual Meeting 9.2%
1/27 Clearside Biomedical Inc (NASDAQ: CLSD) had its price target raised by analysts at Wedbush from $3.00 to $5.00. They now have an "outperform" rating on the stock. 8.5%
3/20 Clearside Biomedical Inc (NASDAQ: CLSD) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating. 7.9%
10/21 Clearside Biomedical Inc (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Wedbush. They now have a $3.00 price target on the stock. 7.3%
8/7 Q2/2019 6/30/2019 EPS -0.150 ZacksConsensus -0.370 ActVsEst 0.220 - Beat 28.0%
10/22 Clearside Biomedical Inc (NASDAQ: CLSD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $1.00 price target on the stock. 19.0%
9/3 Clearside Biomedical to Present at the Janney Montgomery Scott Healthcare Conference 16.0%
11/26 Form 4 Clearside Biomedical, For: Nov 22 Filed by: Thorp Clay 12.5%
4/8 Clearside Biomedical to Present at the Needham Virtual Healthcare Conference 11.7%
10/3 Clearside Biomedical Announces Multiple Presentations to be Given at the American Academy of Ophthalmology (AAO) 2019 Annual Meeting 9.2%
1/27 Clearside Biomedical Inc (NASDAQ: CLSD) had its price target raised by analysts at Wedbush from $3.00 to $5.00. They now have an "outperform" rating on the stock. 8.5%
3/20 Clearside Biomedical Inc (NASDAQ: CLSD) was upgraded by analysts at ValuEngine from a "strong sell" rating to a "sell" rating. 7.9%
10/21 Clearside Biomedical Inc (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Wedbush. They now have a $3.00 price target on the stock. 7.3%
TOP News Decliners
8/22
Form 8-K Clearside Biomedical, For: Aug 22
-40.1%
3/11 Form 8-K Clearside Biomedical, For: Mar 11 -36.0%
3/13 Form 424B5 Clearside Biomedical, -29.5%
4/28 Form 8-K Clearside Biomedical, For: Apr 27 -17.4%
2/27 Clearside Biomedical to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update on Wednesday, March 11, 2020 -14.3%
8/26 Clearside Biomedical Inc (NASDAQ: CLSD) was given a new $1.00 price target on by analysts at Laidlaw. They now have a "hold" rating on the stock. -10.6%
8/22 Clearside Biomedical Inc (NASDAQ: CLSD) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $3.00 price target on the stock, down previously from $4.00. -9.6%
9/4 Form 8-K Clearside Biomedical, For: Aug 29 -9.4%
6/4 Form 4 Clearside Biomedical, For: May 31 Filed by: Raymond Brion S. -8.8%
3/16 Form 8-K Clearside Biomedical, For: Mar 11 -8.8%
3/11 Form 8-K Clearside Biomedical, For: Mar 11 -36.0%
3/13 Form 424B5 Clearside Biomedical, -29.5%
4/28 Form 8-K Clearside Biomedical, For: Apr 27 -17.4%
2/27 Clearside Biomedical to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update on Wednesday, March 11, 2020 -14.3%
8/26 Clearside Biomedical Inc (NASDAQ: CLSD) was given a new $1.00 price target on by analysts at Laidlaw. They now have a "hold" rating on the stock. -10.6%
8/22 Clearside Biomedical Inc (NASDAQ: CLSD) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $3.00 price target on the stock, down previously from $4.00. -9.6%
9/4 Form 8-K Clearside Biomedical, For: Aug 29 -9.4%
6/4 Form 4 Clearside Biomedical, For: May 31 Filed by: Raymond Brion S. -8.8%
3/16 Form 8-K Clearside Biomedical, For: Mar 11 -8.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: